Commonwealth Equity Services’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Commonwealth Equity Services’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-16,700	Closed	-$37K	–	3972
2023 Q2	$37K	Sell	16,700 -300	-2%	-$622	﹤0.01%	3699
2023 Q1	$43	Hold	17,000	–	–	﹤0.01%	3600
2022 Q4	$31K	Buy	+17,000	New	+$42.4K	﹤0.01%	3565

Commonwealth Equity Services's PRTK Position: Q3 2023 in Review

Commonwealth Equity Services sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 16,700 shares — an estimated $37K sold.

Commonwealth Equity Services first reported a position in PRTK in Q4 2022 and held it in 3 quarters. The position peaked at $37K in Q2 2023. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

Commonwealth Equity Services reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Commonwealth Equity Services sold 16,700 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $37K.
Commonwealth Equity Services first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2022 and held it in 3 quarters.
Commonwealth Equity Services's Paratek Pharmaceuticals, Inc. position peaked at $37K in Q2 2023.
0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on Commonwealth Equity Services's 13F filing for Q3 2023, filed 23 Oct 2023.